prikaz prve stranice dokumenta Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness
  Preuzmi
PDF 4.45 MB
Znanstveni rad - Izvorni znanstveni rad
Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness
Frontiers in Immunology, 14 (2023); 1191884. https://doi.org/10.3389/fimmu.2023.1191884
Imširović, Vanna; Lenartić, Maja; Wensveen, Felix M.; Polić, Bojan; Jelenčić, Vedrana

Citirajte ovaj rad

Imširović, V., Lenartić, M., Wensveen, F. M., Polić, B. i Jelenčić, V. (2023). Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness. Frontiers in Immunology, 14.. doi: 10.3389/fimmu.2023.1191884

Imširović, Vanna, et al. "Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness." Frontiers in Immunology, vol. 14, 2023. https://doi.org/10.3389/fimmu.2023.1191884

Imširović, Vanna, Maja Lenartić, Felix M. Wensveen, Bojan Polić i Vedrana Jelenčić. "Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1191884

Imširović, V., et al. (2023) 'Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness', Frontiers in Immunology, 14. doi: 10.3389/fimmu.2023.1191884

Imširović V, Lenartić M, Wensveen FM, Polić B, Jelenčić V. Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness. Frontiers in Immunology [Internet]. 2023. [pristupljeno 03.12.2024.];14. doi: 10.3389/fimmu.2023.1191884

V. Imširović, M. Lenartić, F. M. Wensveen, B. Polić i V. Jelenčić, "Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness", Frontiers in Immunology, vol. 14, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:744755. [Citirano: 03.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:744755
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness
AutorVanna Imširović
AutorMaja Lenartić
AutorFelix M. Wensveen
AutorBojan Polić
AutorVedrana Jelenčić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za histologiju i embriologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Sažetak (engleski)
Natural killer (NK) cells play an important role in the early defense against tumors and virally infected cells. Their function is thought to be controlled by the balance between activating and inhibitory receptors, which often compete for the same ligands. Several activating receptors expressed on virtually all NK cells lack an inhibitory partner, most notably CD16, NCR1 and NKG2D. We therefore hypothesized that a signal through at least one of these receptors is always required for full NK cell activation. We generated animals lacking all three receptors (TKO) and analyzed their NK cells. , TKO NK cells did not show reduced ability to kill tumor targets but displayed hyperresponsiveness to NK1.1 stimulation. , TKO animals had a minor reduction in their ability to control non-hematopoietic tumors and cytomegalovirus infection, which was the result of reduced NK cell activity. Together, our findings show that activating NK cell receptors without an inhibitory partner do not provide a ‘master’ signal but are integrated in the cumulative balance of activating and inhibitory signals. Their activity is controlled through regulation of the responsiveness and expression of other activating receptors. Our findings may be important for future development of NK cell-based cancer immunotherapy.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaFrontiers in Immunology
Brojčani podacivol. 14, 1191884
e-ISSN1664-3224
DOIhttps://doi.org/10.3389/fimmu.2023.1191884
URN:NBNurn:nbn:hr:184:744755
Datum objave publikacije2023
ProjektŠifra: KK.011.1.01.0006
Naziv (engleski): Jačanje kapaciteta CerVirVac-a za istraživanja u virusnoj imunologiji i vakcinologiji
Voditelj: Stipan Jonjić
Pravna nadležnost: eu
Financijer: ERDF
URL dokumentahttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1191884/full
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2023-10-10 13:38:10